MedPath

A Study of Minirin Melt in Patients With Nocturia

Completed
Conditions
Nocturia
Registration Number
NCT01222598
Lead Sponsor
Ferring Pharmaceuticals
Brief Summary

This is a confirmation of safety profile for Minirin Melt in clinical practice.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
588
Inclusion Criteria
  • patients suffering from Nocturia
Exclusion Criteria
  • habitual or psychogenic polydipsia
  • known or suspected cardiac insufficiency and other conditions requiring treatment with diuretics
  • moderate and severe renal insufficiency
  • know hyponatremia
  • syndrome of inappropriate ADH secretion

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Number of participants with adverse events12 months
Secondary Outcome Measures
NameTimeMethod
Number of participants with nocturnal voiding12 months
Number of participants with adverse events12 months

Trial Locations

Locations (28)

Private Ambulance

🇨🇿

Třebíč, Czech Republic

Trauma Hospital in Brno

🇨🇿

Brno, Czech Republic

Urocentrum

🇨🇿

Brno, Czech Republic

Uromeda, s.r.o.

🇨🇿

Brno, Czech Republic

Hospital Dečín

🇨🇿

Děčín, Czech Republic

University Hospital Hradec Králové

🇨🇿

Hradec Králové, Czech Republic

Hospital Jablonec nad Nisou

🇨🇿

Jablonec nad Nisou, Czech Republic

Hospital Jihlava

🇨🇿

Jihlava, Czech Republic

Hospital Kroměříž

🇨🇿

Kroměříž, Czech Republic

Polyclinic Kuřim

🇨🇿

Kuřim, Czech Republic

Scroll for more (18 remaining)
Private Ambulance
🇨🇿Třebíč, Czech Republic

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.